Mirna Therapeutics is First to Advance MicroRNA into the Clinic for Cancer

News   May 14, 2013

 
Mirna Therapeutics is First to Advance MicroRNA into the Clinic for Cancer
 
 
 

RELATED ARTICLES

Finding Drug Targets for Obesity, Diabetes

News

Technological breakthrough will likely be of great interest to biotechnology companies aspiring to build their drug pipeline in the metabolic disease area.

READ MORE

Fabric Genomics Partners to Improve Pediatric Care

News

Partnerships with Genomics England, Rady Children's Institute for Genomic Medicine, and The Utah Genome Project demonstrate diagnostic utility of Fabric Genomics' algorithm-based genome analysis.

READ MORE

Key Cancer-Linked Proteins Thought to be ‘Undruggable’ Until Now

News

A new study published in Nature, conducted by an alliance between industry and academia involving the University of Liverpool, highlights a new approach to targeting key cancer-linked proteins, thought to be ‘undruggable’.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Cancer Research Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE